Swapnadip Roy, 33, was extradited from Italy and made his first court appearance in U.S. District Court in Tampa on Tuesday. He and co-defendant Vicky Ramancha, 37, face an indictment with one count of conspiracy to commit smuggling and to defraud the United States, plus three additional smuggling counts, according to the Department of Justice.
That timeline is central to the case prosecutors have built against them.
Ozempic, the popular diabetes and weight-loss drug, has become a target for counterfeiters as demand and prices have climbed. Fake versions can carry unknown ingredients or the wrong dosage. Patients often have no idea they aren't getting the real thing. The case highlights how counterfeit versions of high-demand medications can slip through supply chains from overseas, even after authorities move to shut them down.
Roy's extradition from Italy to face charges in Florida shows how far federal investigators tracked this alleged pipeline, from manufacturing in China to distribution networks reaching straight into a U.S. Courtroom.